How to invest in cannabis stocks

Saxo Be Invested

Saxo Group

The cannabis industry is attracting high levels of investment due to the potential that many believe it has for rapid growth over the next few years. The cannabis sector emerged after certain parts of the world moved to legalise the drug for medicinal and recreational purposes. While it is an ever-controversial industry to invest in, we want to give you all the information you need, in case you do want to invest in this sector.

In this guide, we summarise the cannabis industry and the various subsectors that you could use to diversify your portfolio, as well as outlining what some of the potential risks are.

What is the state of the cannabis industry?

Worldwide

Ever since Uruguay legalised the recreational use of cannabis in 2013, the industry has been expanding quickly. Canada fully legalised the drug in 2018, becoming the second country in the world to do so. Since then, countries like Georgia, Malta, South Africa, and Mexico have all fully legalised it.

The opening of the German market and the potential for easier financing access over time could improve conditions for the cannabis industry. However, despite significant price drops in recent years, many cannabis stocks remain expensive, reflecting lofty future expectations. Therefore, investors are advised to conduct thorough due diligence before investing in cannabis stocks.

In the USA, at the time of writing (2024), cannabis is legal in 38 of 50 states for medicinal use and 24 states for recreational use.

Projection

Considering that most countries in the world have not yet legalised cannabis, analysts still believe there is huge potential for the industry to boom in the years ahead. A projection from Grandview Research suggests that revenue from the sector could rise at a compound annual growth rate (CAGR) of 18.1 per cent and be worth USD 73.6 billion by the end of 2027. Other projections have been even more optimistic. For instance, Fortune Business insights anticipate a CAGR of close to 33 percent, which would put the global cannabis market size at USD 97.35 billion by the end of 2026.

Even going on the lowest expectations of analysts, it’s still no surprise that the cannabis industry is attracting interest and investment. But, as with any sector, there is always a risk it will not grow as expected, so it’s important to learn as much as possible about the industry if you are considering investing in it. In the next section, we’ll outline the different subsectors in which you can think about investing.

What subsectors make up the cannabis industry?

Before you invest in the cannabis industry, you need to know all the different subsectors so you can identify where the biggest growth could occur or where the best value stocks can be found. There are three main subsectors that contribute to the overall cannabis industry, and each of these represent slightly different investment prospects. These are:

  • Growers and retailers
  • Biotechnology companies
  • Ancillary marijuana businesses

Growers and retailers

Without growers and retailers, there would be no cannabis industry at all. Investors can choose to buy stocks in established companies or look for start-ups that are beginning to grow cannabis in places where it is legal. An example of a company in this subsector is GrowGeneration, a retailer that is one of the largest hydroponics suppliers that sells soil, lighting, and equipment for both commercial and home growers.

Biotechnology companies

Because more countries around the world are moving towards legalising cannabis for medicinal use first, the biotechnology companies that develop pharmaceutical drugs may be worth paying attention to. In the early days, big pharmaceutical companies were being careful with their approach to cannabis, as it was initially seen as a risky area to get into.

However, this changed in 2019 when the world’s largest generic drug manufacturer, Teva, signed a deal with medical cannabis company, Canndoc, to distribute its products.

With the Israel-based company opting to move into cannabis, it has paved the way for others to follow suit. Opportunities for investments here could arise in deals made between big pharma companies and smaller cannabis drug developers.

Ancillary marijuana businesses

The third subsector focuses on ancillary companies that provide products or services related to the cannabis industry. These could represent anything from eCommerce sites, distribution, growing technology, and various other services.

What are the uses of cannabis that can fuel the markets?

There are two main uses of cannabis - recreational or medicinal. By understanding how the drug is used, you can attempt to identify the areas in which you think there will be healthy financial growth in the years ahead.

Medical

Research has shown that the most common use of marijuana for medical purposes in the USA is for pain relief. It’s mainly used for chronic pain associated with age and is viewed as not being as potentially addictive as opiates.

Recreational

Recreational cannabis use covers people who opt to use the drug for their own enjoyment rather than for medical reasons. This can be done in social settings, or alone, and can be compared to other legal drugs like alcohol. There has already been a rise in cannabis cafes in locations where the drug has been legalised, and it is likely there will be future innovation exploring other business opportunities for the recreational use of the drug.

What do you need to know before investing?

While there are various opportunities to invest in the cannabis industry, there are also risks involved. The sector faces numerous challenges, and it will have to overcome these to flourish and achieve sustainability.

Challenges for the cannabis industry

Shifting landscape

An ever-present challenge for the cannabis industry is the rapidly changing legal landscape. Despite being legalised in various places, the laws are not standard across the board. This means that cannabis companies that want to operate on a wide scale need to adjust their business and marketing model depending on the rules in each location they operate in.

Bigger brands moving in

Smaller start-ups in the industry could be at risk of getting swallowed up or muscled out by bigger, well-established brands from other addiction industries including alcohol and tobacco. There has been an increased interest in the cannabis industry from these sectors and companies like Anheuser-Busch InBev, Pabst Brewing Company, and Constellation Brands have all begun to invest in cannabis-related products.

Risks for investors

As most seasoned investors know, stocks with high potential also come with high risk, so you should do thorough research and use as many sources as possible to help you make informed decisions. Below, we’ve listed a couple of the key risks that could cause major issues for investors.

No guarantee of success

Many companies hedge their success solely on the potential they believe the industry has, even though new start-ups often fail. For instance, some of the early medical cannabis companies were unable to provide investors with information about necessary licences and barriers to entering the industry, and subsequently lost their capital because of this.

Legislation could change

The government legislation is still being streamlined in many of the places that have legalised cannabis, and there could be a chance that some governments backtrack on these new laws.

For example, if new research emerges that suggests cannabis isn’t as beneficial for medical purposes as scientists once thought, governments may stop using it for medicinal purposes.

Likewise, if there are other adverse effects from the legalisation of cannabis over the course of a few years, governments could adjust their laws again. Investors should also be aware of how pricing and taxation could change, how share prices can be inflated if there are high levels of interest; and the risk of dilution as companies try to expand to meet demand.

How can you invest in cannabis stocks?

If you want to invest in cannabis stocks, you can do so with most brokers. Here are some investment instruments you may want to look into:

Cannabis stocks

It’s possible to buy shares or stocks directly in companies that operate within the cannabis industry. These companies can work specifically within the subsectors previously mentioned in this guide. Investing in individual stocks allows you to focus on the share price movements of specific companies.

Cannabis ETFs

ETFs (exchange-traded funds) are investment funds traded on stock exchanges, similar to stocks. A cannabis ETF holds assets in various companies within the cannabis industry, providing diversified exposure to the sector. This can mitigate risk compared to investing in individual cannabis stocks.

If investing in cannabis stocks interests you, make sure you do careful research before you get started so you can make the most informed decisions when you start. There is no doubt that the cannabis industry is one to watch, but there is high risk involved due to the lack of certainty about where it will be in the future.

Quarterly Outlook 2024 Q4

01 /

  • Macro Outlook: The US rate cut cycle has begun

    Quarterly Outlook

    Macro Outlook: The US rate cut cycle has begun

    Peter Garnry

    Chief Investment Strategist

    The Fed started the US rate cut cycle in Q3 and in this macro outlook we will explore how the rate c...
  • Fixed Income Outlook: Bonds Hit Reset. A New Equilibrium Emerges

    Quarterly Outlook

    Fixed Income Outlook: Bonds Hit Reset. A New Equilibrium Emerges

    Althea Spinozzi

    Head of Fixed Income Strategy

  • Equity Outlook: Will lower rates lift all boats in equities?

    Quarterly Outlook

    Equity Outlook: Will lower rates lift all boats in equities?

    Peter Garnry

    Chief Investment Strategist

    After a period of historically high equity index concentration driven by the 'Magnificent Seven' sto...
  • FX Outlook: USD in limbo amid political and policy jitters

    Quarterly Outlook

    FX Outlook: USD in limbo amid political and policy jitters

    Charu Chanana

    Head of FX Strategy

    As we enter the final quarter of 2024, currency markets are set for heightened turbulence due to US ...
  • Commodity Outlook: Gold and silver continue to shine bright

    Quarterly Outlook

    Commodity Outlook: Gold and silver continue to shine bright

    Ole Hansen

    Head of Commodity Strategy

  • FX: Risk-on currencies to surge against havens

    Quarterly Outlook

    FX: Risk-on currencies to surge against havens

    Charu Chanana

    Head of FX Strategy

    Explore the outlook for USD, AUD, NZD, and EM carry trades as risk-on currencies are set to outperfo...
  • Equities: Are we blowing bubbles again

    Quarterly Outlook

    Equities: Are we blowing bubbles again

    Peter Garnry

    Chief Investment Strategist

    Explore key trends and opportunities in European equities and electrification theme as market dynami...
  • Macro: Sandcastle economics

    Quarterly Outlook

    Macro: Sandcastle economics

    Peter Garnry

    Chief Investment Strategist

    Explore the "two-lane economy," European equities, energy commodities, and the impact of US fiscal p...
  • Bonds: What to do until inflation stabilises

    Quarterly Outlook

    Bonds: What to do until inflation stabilises

    Althea Spinozzi

    Head of Fixed Income Strategy

    Discover strategies for managing bonds as US and European yields remain rangebound due to uncertain ...
  • Commodities: Energy and grains in focus as metals pause

    Quarterly Outlook

    Commodities: Energy and grains in focus as metals pause

    Ole Hansen

    Head of Commodity Strategy

    Energy and grains to shine as metals pause. Discover key trends and market drivers for commodities i...

Disclaimer

The Saxo Bank Group entities each provide execution-only service and access to Analysis permitting a person to view and/or use content available on or via the website. This content is not intended to and does not change or expand on the execution-only service. Such access and use are at all times subject to (i) The Terms of Use; (ii) Full Disclaimer; (iii) The Risk Warning; (iv) the Rules of Engagement and (v) Notices applying to Saxo News & Research and/or its content in addition (where relevant) to the terms governing the use of hyperlinks on the website of a member of the Saxo Bank Group by which access to Saxo News & Research is gained. Such content is therefore provided as no more than information. In particular no advice is intended to be provided or to be relied on as provided nor endorsed by any Saxo Bank Group entity; nor is it to be construed as solicitation or an incentive provided to subscribe for or sell or purchase any financial instrument. All trading or investments you make must be pursuant to your own unprompted and informed self-directed decision. As such no Saxo Bank Group entity will have or be liable for any losses that you may sustain as a result of any investment decision made in reliance on information which is available on Saxo News & Research or as a result of the use of the Saxo News & Research. Orders given and trades effected are deemed intended to be given or effected for the account of the customer with the Saxo Bank Group entity operating in the jurisdiction in which the customer resides and/or with whom the customer opened and maintains his/her trading account. Saxo News & Research does not contain (and should not be construed as containing) financial, investment, tax or trading advice or advice of any sort offered, recommended or endorsed by Saxo Bank Group and should not be construed as a record of our trading prices, or as an offer, incentive or solicitation for the subscription, sale or purchase in any financial instrument. To the extent that any content is construed as investment research, you must note and accept that the content was not intended to and has not been prepared in accordance with legal requirements designed to promote the independence of investment research and as such, would be considered as a marketing communication under relevant laws.

Please read our disclaimers:
Notification on Non-Independent Investment Research (https://www.home.saxo/legal/niird/notification)
Full disclaimer (https://www.home.saxo/legal/disclaimer/saxo-disclaimer)


Business Hills Park – Building 4,
4th Floor, office 401, Dubai Hills Estate, P.O. Box 33641, Dubai, UAE

Contact Saxo

Select region

UAE
UAE

Trade responsibly
All trading carries risk. Read more. To help you understand the risks involved we have put together a series of Key Information Documents (KIDs) highlighting the risks and rewards related to each product. Read more

Saxo Bank A/S is licensed by the Danish Financial Supervisory Authority and operates in the UAE under a representative office license issued by the Central bank of the UAE.

The content and material made available on this website and the linked sites are provided by Saxo Bank A/S. It is the sole responsibility of the recipient to ascertain the terms of and comply with any local laws or regulation to which they are subject.

The UAE Representative Office of Saxo Bank A/S markets the Saxo Bank A/S trading platform and the products offered by Saxo Bank A/S.